| Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
| Cefuroxime sodium |
Is a |
False |
Cefuroxime (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Cefuroxime axetil |
Is a |
False |
Cefuroxime (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Cefuroxime measurement |
Component |
True |
Cefuroxime (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Cefuroxime poisoning |
Causative agent (attribute) |
True |
Cefuroxime (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Accidental cefuroxime poisoning |
Causative agent (attribute) |
False |
Cefuroxime (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Intentional cefuroxime poisoning |
Causative agent (attribute) |
False |
Cefuroxime (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| intoxication par le céfuroxime d'intention indéterminée |
Causative agent (attribute) |
False |
Cefuroxime (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Cefuroxime adverse reaction |
Causative agent (attribute) |
True |
Cefuroxime (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Allergy to cefuroxime |
Causative agent (attribute) |
False |
Cefuroxime (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Cefuroxime overdose (disorder) |
Causative agent (attribute) |
True |
Cefuroxime (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Accidental cefuroxime overdose |
Causative agent (attribute) |
True |
Cefuroxime (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Intentional cefuroxime overdose |
Causative agent (attribute) |
True |
Cefuroxime (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| surdose de céfuroxime d'intention indéterminée |
Causative agent (attribute) |
False |
Cefuroxime (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing precisely cefuroxime 125 milligram/1 each conventional release oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cefuroxime (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Cefuroxime 250mg tablet (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cefuroxime (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing precisely cefuroxime (as cefuroxime axetil) 125 milligram/1 sachet granules for conventional release oral suspension (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cefuroxime (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing precisely cefuroxime (as cefuroxime sodium) 250 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cefuroxime (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing cefuroxime and metronidazole (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Cefuroxime (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
| Cefuroxime 5% preservative-free eye drops (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cefuroxime (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Cefuroxime-containing product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Cefuroxime (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Cefuroxime-containing product in parenteral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Cefuroxime (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing precisely cefuroxime 500 milligram/1 each conventional release oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cefuroxime (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing cefuroxime (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Cefuroxime (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Accidental cefuroxime poisoning |
Causative agent (attribute) |
True |
Cefuroxime (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Intentional cefuroxime poisoning |
Causative agent (attribute) |
True |
Cefuroxime (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing cefuroxime in ophthalmic dosage form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cefuroxime (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Allergy to cefuroxime |
Causative agent (attribute) |
True |
Cefuroxime (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing precisely cefuroxime 125 milligram/1 each conventional release oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cefuroxime (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing precisely cefuroxime 125 milligram/1 each conventional release oral tablet |
Has basis of strength substance (attribute) |
False |
Cefuroxime (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Cefuroxime 250mg tablet (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cefuroxime (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Cefuroxime 250mg tablet (substance) |
Has basis of strength substance (attribute) |
False |
Cefuroxime (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing precisely cefuroxime 500 milligram/1 each conventional release oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cefuroxime (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing precisely cefuroxime 500 milligram/1 each conventional release oral tablet |
Has basis of strength substance (attribute) |
False |
Cefuroxime (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Cefuroxime sodium |
Is modification of (attribute) |
True |
Cefuroxime (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Cefuroxime axetil |
Is modification of (attribute) |
True |
Cefuroxime (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing precisely cefuroxime 500 milligram/1 each conventional release oral tablet |
Has precise active ingredient |
False |
Cefuroxime (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing precisely cefuroxime 125 milligram/1 each conventional release oral tablet |
Has precise active ingredient |
False |
Cefuroxime (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Cefuroxime 250mg tablet (substance) |
Has precise active ingredient |
False |
Cefuroxime (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing precisely cefuroxime (as cefuroxime axetil) 125 milligram/1 sachet granules for conventional release oral suspension (clinical drug) |
Has basis of strength substance (attribute) |
True |
Cefuroxime (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing precisely cefuroxime (as cefuroxime sodium) 250 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
Has basis of strength substance (attribute) |
True |
Cefuroxime (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Cefuroxime (as cefuroxime axetil) 25 mg/mL oral suspension |
Has basis of strength substance (attribute) |
True |
Cefuroxime (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Cefuroxime (as cefuroxime sodium) 50 mg/mL eye drops |
Has basis of strength substance (attribute) |
True |
Cefuroxime (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing precisely cefuroxime (as cefuroxime sodium) 1.5 gram/50 milliliter conventional release solution for infusion bag |
Has basis of strength substance (attribute) |
False |
Cefuroxime (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing precisely cefuroxime (as cefuroxime sodium) 750 milligram/50 milliliter conventional release solution for infusion bag |
Has basis of strength substance (attribute) |
False |
Cefuroxime (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Cefuroxime-containing product in ocular dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Cefuroxime (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Cefuroxime only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Cefuroxime (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing only cefuroxime and metronidazole (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Cefuroxime (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
| Product containing only cefuroxime in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Cefuroxime (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Cefuroxime only product in ocular dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Cefuroxime (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Cefuroxime only product in parenteral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Cefuroxime (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Cefuroxime (as cefuroxime sodium) 15 mg/mL solution for infusion |
Has basis of strength substance (attribute) |
True |
Cefuroxime (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing precisely cefuroxime (as cefuroxime sodium) 30 milligram/1 milliliter conventional release solution for infusion (clinical drug) |
Has basis of strength substance (attribute) |
True |
Cefuroxime (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing precisely cefuroxime (as cefuroxime axetil) 250 milligram/1 each conventional release oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
True |
Cefuroxime (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Cefuroxime (as cefuroxime axetil) 125 mg oral tablet |
Has basis of strength substance (attribute) |
True |
Cefuroxime (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing precisely cefuroxime (as cefuroxime axetil) 50 milligram/1 milliliter conventional release oral suspension (clinical drug) |
Has basis of strength substance (attribute) |
True |
Cefuroxime (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Cefuroxime (as cefuroxime axetil) 500 mg oral tablet |
Has basis of strength substance (attribute) |
True |
Cefuroxime (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Cefuroxime (as cefuroxime sodium) 30 mg/mL solution for injection |
Has basis of strength substance (attribute) |
True |
Cefuroxime (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Cefuroxime (as cefuroxime sodium) 15 mg/mL solution for injection |
Has basis of strength substance (attribute) |
True |
Cefuroxime (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing precisely cefuroxime (as cefuroxime sodium) 750 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
Has basis of strength substance (attribute) |
True |
Cefuroxime (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing precisely cefuroxime (as cefuroxime sodium) 1.5 gram/1 vial powder for conventional release solution for injection (clinical drug) |
Has basis of strength substance (attribute) |
True |
Cefuroxime (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing precisely cefuroxime (as cefuroxime axetil) 125 milligram/1 each tablet for conventional release oral suspension (clinical drug) |
Has basis of strength substance (attribute) |
True |
Cefuroxime (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing precisely cefuroxime (as cefuroxime sodium) 50 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
Has basis of strength substance (attribute) |
True |
Cefuroxime (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Cefuroxime (as cefuroxime sodium) 15 mg/mL solution for infusion and/or injection |
Has basis of strength substance (attribute) |
True |
Cefuroxime (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Cefuroxime (as cefuroxime sodium) 30 mg/mL solution for infusion and/or injection |
Has basis of strength substance (attribute) |
True |
Cefuroxime (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing cefuroxime and clavulanic acid (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Cefuroxime (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Cefuroxime and clavulanic acid only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Cefuroxime (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing cefuroxime and clavulanic acid in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Cefuroxime (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing only cefuroxime and clavulanic acid in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Cefuroxime (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing precisely cefuroxime (as cefuroxime axetil) 500 milligram and clavulanic acid (as clavulanate potassium) 125 milligram/1 each conventional release oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
True |
Cefuroxime (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing precisely cefuroxime (as cefuroxime sodium) 1.5 gram/1 vial powder for conventional release solution for infusion and/or injection (clinical drug) |
Has basis of strength substance (attribute) |
True |
Cefuroxime (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Cefuroxime (as cefuroxime sodium) 750 mg powder for solution for infusion and/or injection vial |
Has basis of strength substance (attribute) |
True |
Cefuroxime (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
FHIR
© HL7.org
|
Server Home |
FHIR Server FHIR Server 3.7.4-SNAPSHOT
|
FHIR Version n/a
User: [n/a]